- Financial Markets Worldwide

Please try another search

Economy4 hours ago (Jan 13, 2022 08:13AM ET)

© Reuters. A man walks past a sign reading “Yes, we have antigen tests” on the window of a pharmacy amid the coronavirus disease (COVID-19) pandemic in Madrid, Spain, January 12, 2022. REUTERS/Susana Vera

MADRID (Reuters) – Spain will cap prices for rapid coronavirus tests and open up its booster shot programme to everyone over the age of 18, the government said on Thursday, a day after data showed Omicron’s rampant spread might be starting to slow.

Health Minister Carolina Darias said that from Saturday antigen tests would be sold to the public for a maximum of 2.94 euros ($3.37), bringing prices closer in line with other European countries.

“Our objective was first to stabilise the supply after demand increased by a factor of over 1,000 – and then we focused on regulating prices,” Darias told reporters.

Spain had sporadic shortages of antigen tests throughout December amid a sudden spike in demand because of Omicron’s high transmissibility and people wanting to get tests during the year-end festivities.

Antigen tests are currently are only available for sale in pharmacies in Spain, despite calls from supermarket lobby groups and some health experts to allow their sale in supermarkets, as neighbouring Portugal has done.

Carolina Darias added that the interval between people receiving the last dose of the vaccine and the booster shot will be cut to five months from six months.

“Reducing the period between last dose and booster is in consonance with the countries in our region, and is part of a strategic response which is constantly evolving,” Darias said, noting that the vaccine drive would proceed from older to younger age groups.

Related Articles

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *